Fig. 2From: Outsmarting trogocytosis to boost CAR NK/T cell therapyPotential approaches to enhance CAR-Cell antitumoral functions by modulating trogocytosis. Several strategies can be employed to boost antitumoral functions of these cells, including pharmacological targeting, dual CAR strategy, affinity modulation of CARs, implementing armored CAR constructs, and adjusting the signaling domainsBack to article page